APO Research
Talk to an analyst

APO RESEARCH · REPORT

Laboratory-developed Testing

Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.

A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.

LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.

While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.

Selected research

Market Analysis & Forecast

Global Laboratory-developed Testing Market Analysis and Forecast 2026-2032

26 December 2025197 pages

Choose your research edition.

Industry ResearchLaboratory-developed Testing Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Laboratory-developed Testing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Laboratory-developed Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Laboratory-developed Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Laboratory-developed Testing Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Twenty-five years ago, the Food and Drug Administration (FDA) asserted in a draft document that "home brew" tests-now commonly referred to as laboratory-developed tests (LDTs)-are subject to the same regulatory oversight as other in vitro diagnostics (IVDs)4. In 2010, the FDA began work on developing a proposed framework for future LDT oversight. Released in 2014, the draft guidance sparked an intense debate over potential LDT regulation. While the proposed guidance has not been implemented, many questions regarding LDT oversight remain unresolved.

A laboratory developed test (LDT) is a type of in vitro diagnostic test that is designed, manufactured and used within a single laboratory.

LDTs can be used to measure or detect a wide variety of analytes (substances such as proteins, chemical compounds like glucose or cholesterol, or DNA), in a sample taken from a human body. Some LDTs are relatively simple tests that measure single analytes, such as a test that measures the level of sodium. Other LDTs are complex and may measure or detect one or more analytes. For example, some tests can detect many DNA variations from a single blood sample, which can be used to help diagnose a genetic disease. Various levels of chemicals can be measured to help diagnose a patient’s state of health, such as levels of cholesterol or sodium.

Read the full market overview

While the uses of an LDT are often the same as the uses of FDA-cleared or approved in vitro diagnostic tests, some labs may choose to offer their own test. For example, a hospital lab may run its own vitamin D assay, even though there is an FDA-cleared test for vitamin D currently on the market.

The leading players in laboratory-developed testing include Quest Diagnostics, Roche, Illumina, Qiagen, and Eurofins, with the top three accounting for approximately 15% of the market.

North America is the largest market with more than 65% of the market, followed by Europe with about 15%.

Report Includes

This report presents an overview of global market for Laboratory-developed Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Laboratory-developed Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Laboratory-developed Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Laboratory-developed Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Laboratory-developed Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Laboratory-developed Testing revenue, projected growth trends, production technology, application and end-user industry.

Laboratory-developed Testing Segment by Company

Adaptive Biotechnologies Corporation

Quest Diagnostics

Roche

Illumina

Qiagen

Eurofins

Guardant Health

Biotheranostics

Adaptive Biotechnologies

Rosetta Genomics

Biodesix

Helix

Laboratory-developed Testing Segment by Type

Commercial Service

R&D

Laboratory-developed Testing Segment by Application

Genetic Testing

Oncology

Infectious Disease

Others

Laboratory-developed Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Laboratory-developed Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Laboratory-developed Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Laboratory-developed Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Laboratory-developed Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Laboratory-developed Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Laboratory-developed Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Laboratory-developed Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Commercial Service Major Player Table 3. R&D Major Player Table 4. Global Laboratory-developed Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Genetic Testing Major Player Table 6. Oncology Major Player Table 7. Infectious Disease Major Player Table 8. Others Major Player Table 9. Laboratory-developed Testing Industry Trends Table 10. Laboratory-developed Testing Industry Drivers Table 11. Laboratory-developed Testing Industry Opportunities and Challenges Table 12. Laboratory-developed Testing Industry Restraints Table 13. Global Laboratory-developed Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Laboratory-developed Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Laboratory-developed Testing Market Share by Region (2021-2026) Table 16. Global Laboratory-developed Testing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Laboratory-developed Testing Market Share by Region (2027-2032) Table 18. Global Laboratory-developed Testing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Laboratory-developed Testing Revenue Market Share by Players (2021-2026) Table 20. Global Laboratory-developed Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Laboratory-developed Testing Key Players Headquarters & Area Served Table 22. Global Laboratory-developed Testing Players, Product Type & Application Table 23. Global Laboratory-developed Testing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Laboratory-developed Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Laboratory-developed Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Laboratory-developed Testing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Laboratory-developed Testing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Laboratory-developed Testing Revenue Market Share by Type (2021-2026) Table 30. Global Laboratory-developed Testing Revenue Market Share by Type (2027-2032) Table 31. Global Laboratory-developed Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Laboratory-developed Testing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Laboratory-developed Testing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Laboratory-developed Testing Revenue Market Share by Application (2021-2026) Table 35. Global Laboratory-developed Testing Revenue Market Share by Application (2027-2032) Table 36. Adaptive Biotechnologies Corporation Company Information Table 37. Adaptive Biotechnologies Corporation Business Overview Table 38. Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Adaptive Biotechnologies Corporation Laboratory-developed Testing Product Portfolio Table 40. Adaptive Biotechnologies Corporation Recent Development Table 41. Quest Diagnostics Company Information Table 42. Quest Diagnostics Business Overview Table 43. Quest Diagnostics Laboratory-developed Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Quest Diagnostics Laboratory-developed Testing Product Portfolio Table 45. Quest Diagnostics Recent Development Table 46. Roche Company Information Table 47. Roche Business Overview Table 48. Roche Laboratory-developed Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Roche Laboratory-developed Testing Product Portfolio Table 50. Roche Recent Development Table 51. Illumina Company Information Table 52. Illumina Business Overview Table 53. Illumina Laboratory-developed Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Illumina Laboratory-developed Testing Product Portfolio Table 55. Illumina Recent Development Table 56. Qiagen Company Information Table 57. Qiagen Business Overview Table 58. Qiagen Laboratory-developed Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Qiagen Laboratory-developed Testing Product Portfolio Table 60. Qiagen Recent Development Table 61. Eurofins Company Information Table 62. Eurofins Business Overview Table 63. Eurofins Laboratory-developed Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Eurofins Laboratory-developed Testing Product Portfolio Table 65. Eurofins Recent Development Table 66. Guardant Health Company Information Table 67. Guardant Health Business Overview Table 68. Guardant Health Laboratory-developed Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Guardant Health Laboratory-developed Testing Product Portfolio Table 70. Guardant Health Recent Development Table 71. Biotheranostics Company Information Table 72. Biotheranostics Business Overview Table 73. Biotheranostics Laboratory-developed Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Biotheranostics Laboratory-developed Testing Product Portfolio Table 75. Biotheranostics Recent Development Table 76. Adaptive Biotechnologies Company Information Table 77. Adaptive Biotechnologies Business Overview Table 78. Adaptive Biotechnologies Laboratory-developed Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Adaptive Biotechnologies Laboratory-developed Testing Product Portfolio Table 80. Adaptive Biotechnologies Recent Development Table 81. Rosetta Genomics Company Information Table 82. Rosetta Genomics Business Overview Table 83. Rosetta Genomics Laboratory-developed Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Rosetta Genomics Laboratory-developed Testing Product Portfolio Table 85. Rosetta Genomics Recent Development Table 86. Biodesix Company Information Table 87. Biodesix Business Overview Table 88. Biodesix Laboratory-developed Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Biodesix Laboratory-developed Testing Product Portfolio Table 90. Biodesix Recent Development Table 91. Helix Company Information Table 92. Helix Business Overview Table 93. Helix Laboratory-developed Testing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Helix Laboratory-developed Testing Product Portfolio Table 95. Helix Recent Development Table 96. North America Laboratory-developed Testing Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Laboratory-developed Testing Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Laboratory-developed Testing Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Laboratory-developed Testing Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Laboratory-developed Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Laboratory-developed Testing Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Laboratory-developed Testing Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Laboratory-developed Testing Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Laboratory-developed Testing Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Laboratory-developed Testing Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Laboratory-developed Testing Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Laboratory-developed Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Laboratory-developed Testing Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Laboratory-developed Testing Revenue by Country (US$ Million) & (2027-2032) Table 110. China Laboratory-developed Testing Revenue by Type (2021-2026) & (US$ Million) Table 111. China Laboratory-developed Testing Revenue by Type (2027-2032) & (US$ Million) Table 112. China Laboratory-developed Testing Revenue by Application (2021-2026) & (US$ Million) Table 113. China Laboratory-developed Testing Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Laboratory-developed Testing Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Laboratory-developed Testing Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Laboratory-developed Testing Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Laboratory-developed Testing Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Laboratory-developed Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Laboratory-developed Testing Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Laboratory-developed Testing Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Laboratory-developed Testing Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Laboratory-developed Testing Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Laboratory-developed Testing Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Laboratory-developed Testing Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Laboratory-developed Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Laboratory-developed Testing Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Laboratory-developed Testing Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Laboratory-developed Testing Image Figure 2. Global Laboratory-developed Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Laboratory-developed Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Commercial Service Image Figure 5. R&D Image Figure 6. Global Laboratory-developed Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Laboratory-developed Testing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Genetic Testing Image Figure 9. Oncology Image Figure 10. Infectious Disease Image Figure 11. Others Image Figure 12. Global Laboratory-developed Testing Market Size (US$ Million) & (2021-2032) Figure 13. Global Laboratory-developed Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Laboratory-developed Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Laboratory-developed Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Laboratory-developed Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Laboratory-developed Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Laboratory-developed Testing Revenue Market Share by Type (2021-2032) Figure 20. Global Laboratory-developed Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Laboratory-developed Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Laboratory-developed Testing Revenue Market Share by Application (2021-2032) Figure 23. North America Laboratory-developed Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Laboratory-developed Testing Revenue Share by Type (2021-2032) Figure 25. North America Laboratory-developed Testing Revenue Share by Application (2021-2032) Figure 26. North America Laboratory-developed Testing Revenue Share by Country (2021-2032) Figure 27. United States Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Laboratory-developed Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Laboratory-developed Testing Revenue Share by Type (2021-2032) Figure 32. Europe Laboratory-developed Testing Revenue Share by Application (2021-2032) Figure 33. Europe Laboratory-developed Testing Revenue Share by Country (2021-2032) Figure 34. Germany Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Laboratory-developed Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Laboratory-developed Testing Revenue Share by Type (2021-2032) Figure 44. China Laboratory-developed Testing Revenue Share by Application (2021-2032) Figure 45. Asia Laboratory-developed Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Laboratory-developed Testing Revenue Share by Type (2021-2032) Figure 47. Asia Laboratory-developed Testing Revenue Share by Application (2021-2032) Figure 48. Asia Laboratory-developed Testing Revenue Share by Region (2021-2032) Figure 49. Japan Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Laboratory-developed Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Laboratory-developed Testing Revenue Share by Type (2021-2032) Figure 57. SAMEA Laboratory-developed Testing Revenue Share by Application (2021-2032) Figure 58. SAMEA Laboratory-developed Testing Revenue Share by Country (2021-2032) Figure 59. Brazil Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Laboratory-developed Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Commercial Service
  • R&D
Applications
  • Genetic Testing
  • Oncology
  • Infectious Disease
  • Others
Companies covered
  • Adaptive Biotechnologies Corporation
  • Quest Diagnostics
  • Roche
  • Illumina
  • Qiagen
  • Eurofins
  • Guardant Health
  • Biotheranostics
  • Adaptive Biotechnologies
  • Rosetta Genomics
  • Biodesix
  • Helix

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Laboratory-developed Testing Market by Type
  3. 1.2.1 Global Laboratory-developed Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Commercial Service
  5. 1.2.3 R&D
  6. 1.3 Laboratory-developed Testing Market by Application
  7. 1.3.1 Global Laboratory-developed Testing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Genetic Testing
  9. 1.3.3 Oncology
  10. 1.3.4 Infectious Disease
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Laboratory-developed Testing Market Dynamics
  1. 2.1 Laboratory-developed Testing Industry Trends
  2. 2.2 Laboratory-developed Testing Industry Drivers
  3. 2.3 Laboratory-developed Testing Industry Opportunities and Challenges
  4. 2.4 Laboratory-developed Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Laboratory-developed Testing Market Perspective (2021-2032)
  2. 3.2 Global Laboratory-developed Testing Growth Trends by Region
  3. 3.2.1 Global Laboratory-developed Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Laboratory-developed Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Laboratory-developed Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Laboratory-developed Testing Revenue by Players
  2. 4.1.1 Global Laboratory-developed Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Laboratory-developed Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Laboratory-developed Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Laboratory-developed Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Laboratory-developed Testing Key Players Headquarters & Area Served
  7. 4.4 Global Laboratory-developed Testing Players, Product Type & Application
  8. 4.5 Global Laboratory-developed Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Laboratory-developed Testing Market CR5 and HHI
  11. 4.6.3 2025 Laboratory-developed Testing Tier 1, Tier 2, and Tier 3
5 Laboratory-developed Testing Market Size by Type
  1. 5.1 Global Laboratory-developed Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Laboratory-developed Testing Revenue by Type (2021-2032)
  3. 5.3 Global Laboratory-developed Testing Revenue Market Share by Type (2021-2032)
6 Laboratory-developed Testing Market Size by Application
  1. 6.1 Global Laboratory-developed Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Laboratory-developed Testing Revenue by Application (2021-2032)
  3. 6.3 Global Laboratory-developed Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Adaptive Biotechnologies Corporation
  2. 7.1.1 Adaptive Biotechnologies Corporation Company Information
  3. 7.1.2 Adaptive Biotechnologies Corporation Business Overview
  4. 7.1.3 Adaptive Biotechnologies Corporation Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Adaptive Biotechnologies Corporation Laboratory-developed Testing Product Portfolio
  6. 7.1.5 Adaptive Biotechnologies Corporation Recent Developments
  7. 7.2 Quest Diagnostics
  8. 7.2.1 Quest Diagnostics Company Information
  9. 7.2.2 Quest Diagnostics Business Overview
  10. 7.2.3 Quest Diagnostics Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Quest Diagnostics Laboratory-developed Testing Product Portfolio
  12. 7.2.5 Quest Diagnostics Recent Developments
  13. 7.3 Roche
  14. 7.3.1 Roche Company Information
  15. 7.3.2 Roche Business Overview
  16. 7.3.3 Roche Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Roche Laboratory-developed Testing Product Portfolio
  18. 7.3.5 Roche Recent Developments
  19. 7.4 Illumina
  20. 7.4.1 Illumina Company Information
  21. 7.4.2 Illumina Business Overview
  22. 7.4.3 Illumina Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Illumina Laboratory-developed Testing Product Portfolio
  24. 7.4.5 Illumina Recent Developments
  25. 7.5 Qiagen
  26. 7.5.1 Qiagen Company Information
  27. 7.5.2 Qiagen Business Overview
  28. 7.5.3 Qiagen Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Qiagen Laboratory-developed Testing Product Portfolio
  30. 7.5.5 Qiagen Recent Developments
  31. 7.6 Eurofins
  32. 7.6.1 Eurofins Company Information
  33. 7.6.2 Eurofins Business Overview
  34. 7.6.3 Eurofins Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Eurofins Laboratory-developed Testing Product Portfolio
  36. 7.6.5 Eurofins Recent Developments
  37. 7.7 Guardant Health
  38. 7.7.1 Guardant Health Company Information
  39. 7.7.2 Guardant Health Business Overview
  40. 7.7.3 Guardant Health Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Guardant Health Laboratory-developed Testing Product Portfolio
  42. 7.7.5 Guardant Health Recent Developments
  43. 7.8 Biotheranostics
  44. 7.8.1 Biotheranostics Company Information
  45. 7.8.2 Biotheranostics Business Overview
  46. 7.8.3 Biotheranostics Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Biotheranostics Laboratory-developed Testing Product Portfolio
  48. 7.8.5 Biotheranostics Recent Developments
  49. 7.9 Adaptive Biotechnologies
  50. 7.9.1 Adaptive Biotechnologies Company Information
  51. 7.9.2 Adaptive Biotechnologies Business Overview
  52. 7.9.3 Adaptive Biotechnologies Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Adaptive Biotechnologies Laboratory-developed Testing Product Portfolio
  54. 7.9.5 Adaptive Biotechnologies Recent Developments
  55. 7.10 Rosetta Genomics
  56. 7.10.1 Rosetta Genomics Company Information
  57. 7.10.2 Rosetta Genomics Business Overview
  58. 7.10.3 Rosetta Genomics Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Rosetta Genomics Laboratory-developed Testing Product Portfolio
  60. 7.10.5 Rosetta Genomics Recent Developments
  61. 7.11 Biodesix
  62. 7.11.1 Biodesix Company Information
  63. 7.11.2 Biodesix Business Overview
  64. 7.11.3 Biodesix Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Biodesix Laboratory-developed Testing Product Portfolio
  66. 7.11.5 Biodesix Recent Developments
  67. 7.12 Helix
  68. 7.12.1 Helix Company Information
  69. 7.12.2 Helix Business Overview
  70. 7.12.3 Helix Laboratory-developed Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Helix Laboratory-developed Testing Product Portfolio
  72. 7.12.5 Helix Recent Developments
8 North America
  1. 8.1 North America Laboratory-developed Testing Revenue (2021-2032)
  2. 8.2 North America Laboratory-developed Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Laboratory-developed Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Laboratory-developed Testing Revenue by Type (2027-2032)
  5. 8.3 North America Laboratory-developed Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Laboratory-developed Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Laboratory-developed Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Laboratory-developed Testing Revenue by Application (2027-2032)
  9. 8.5 North America Laboratory-developed Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Laboratory-developed Testing Revenue by Country
  11. 8.6.1 North America Laboratory-developed Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Laboratory-developed Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Laboratory-developed Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Laboratory-developed Testing Revenue (2021-2032)
  2. 9.2 Europe Laboratory-developed Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Laboratory-developed Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Laboratory-developed Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Laboratory-developed Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Laboratory-developed Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Laboratory-developed Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Laboratory-developed Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Laboratory-developed Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Laboratory-developed Testing Revenue by Country
  11. 9.6.1 Europe Laboratory-developed Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Laboratory-developed Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Laboratory-developed Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Laboratory-developed Testing Revenue (2021-2032)
  2. 10.2 China Laboratory-developed Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Laboratory-developed Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Laboratory-developed Testing Revenue by Type (2027-2032)
  5. 10.3 China Laboratory-developed Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Laboratory-developed Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Laboratory-developed Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Laboratory-developed Testing Revenue by Application (2027-2032)
  9. 10.5 China Laboratory-developed Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Laboratory-developed Testing Revenue (2021-2032)
  2. 11.2 Asia Laboratory-developed Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Laboratory-developed Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Laboratory-developed Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Laboratory-developed Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Laboratory-developed Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Laboratory-developed Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Laboratory-developed Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Laboratory-developed Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Laboratory-developed Testing Revenue by Country
  11. 11.6.1 Asia Laboratory-developed Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Laboratory-developed Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Laboratory-developed Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Laboratory-developed Testing Revenue (2021-2032)
  2. 12.2 SAMEA Laboratory-developed Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Laboratory-developed Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Laboratory-developed Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Laboratory-developed Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Laboratory-developed Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Laboratory-developed Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Laboratory-developed Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Laboratory-developed Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Laboratory-developed Testing Revenue by Country
  11. 12.6.1 SAMEA Laboratory-developed Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Laboratory-developed Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Laboratory-developed Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst